Comment on "Effect of one-year lumacaftor-ivacaftor treatment on glucose tolerance abnormalities in cystic fibrosis patients"

被引：3
|
作者：
Ballmann, Manfred [1 ]
Prinz, Nicole [2 ]
Glass, Aenne [3 ]
Holl, Reinhard [2 ]
机构：
[1] Univ Med Pediat Clin, Ernst Heydemann Str 8, D-18057 Rostock, Germany
[2] Univ Ulm, Inst Epidemiol & Med Biometry, Albert Einstein Allee 41, D-89081 Ulm, Germany
[3] Univ Med Rostock, Inst Biostat & Informat Med & Age Res IBIMA, Ernst Heydemann Str 8, D-18057 Rostock, Germany
来源：
JOURNAL OF CYSTIC FIBROSIS | 2020年 / 19卷 / 05期
关键词：
D O I：
10.1016/j.jcf.2020.04.009
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：839 / 839
页数：1
相关论文
共 50 条
  • [21] Effects of Lumacaftor-Ivacaftor Therapy on CFTR Function in Phe508del Homozygous Patients with Cystic Fibrosis
    Graeber, Simon
    Dopfer, Christian
    Naehrlich, Lutz
    Gyulumyan, Lena
    Scheuermann, Heike
    Hirtz, Stephanie
    Wege, Sabine
    Mairbaeurl, Heimo
    Dorda, Marie
    Hyde, Rebecca
    Bagheri-Hanson, Azadeh
    Rueckes-Nilges, Claudia
    Fischer, Sebastian
    Mall, Marcus A.
    Tuemmler, Burkhard
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [22] Lumacaftor/ Ivacaftor improves exercise tolerance in patients with Cystic Fibrosis and severe airflow obstruction
    Peter A. B. Wark
    Kim Cookson
    Theeba Thiruchelvam
    John Brannan
    Douglas J. Dorahy
    BMC Pulmonary Medicine, 19
  • [23] Safety and efficacy of treatment with lumacaftor in combination with ivacaftor in younger patients with cystic fibrosis
    Cheng, Pi Chun
    Alexiou, Stamatia
    Rubenstein, Ronald C.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2019, 13 (05) : 417 - 423
  • [24] EFFECTS OF LUMACAFTOR-IVACAFTOR THERAPY ON CFTR FUNCTION IN PHE508DEL HOMOZYGOUS PATIENTS WITH CYSTIC FIBROSIS
    Graeber, S. Y.
    Dopfer, C.
    Naehrlich, L.
    Gyulumyan, L.
    Scheuermann, H.
    Hirtz, S.
    Wege, S.
    Mairbaeurl, H.
    Dorda, M.
    Hyde, R.
    Bagheri-Hanson, A.
    Rueckes-Nilges, C.
    Fischer, S.
    Mall, M. A.
    Tummler, B.
    PEDIATRIC PULMONOLOGY, 2018, 53 : 235 - 235
  • [25] Effects of Lumacaftor-Ivacaftor Therapy on Cystic Fibrosis Transmembrane Conductance Regulator Function in Phe508del Homozygous Patients with Cystic Fibrosis
    Graeber, Simon Y.
    Dopfer, Christian
    Naehrlich, Lutz
    Gyulumyan, Lena
    Scheuermann, Heike
    Hirtz, Stephanie
    Wege, Sabine
    Mairbaeurl, Heimo
    Dorda, Marie
    Hyde, Rebecca
    Bagheri-Hanson, Azadeh
    Rueckes-Nilges, Claudia
    Fischer, Sebastian
    Mall, Marcus A.
    Tuemmler, Burkhard
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (11) : 1433 - 1442
  • [26] Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment
    Ejiofor, Linnea Chika Kristensen
    Mathiesen, Inger Hee Mabuza
    Jensen-Fangel, Soren
    Olesen, Hanne Vebert
    Skov, Marianne
    Philipsen, Lue Katrine Drasbaek
    Pedersen, Camilla Lundgren
    Pressler, Tacjana
    PEDIATRIC PULMONOLOGY, 2020, 55 (12) : 3364 - 3370
  • [27] Changes in Glucose Breath Test in Cystic Fibrosis Patients Treated With 1 Month of Lumacaftor/Ivacaftor
    Gabel, Megan E.
    Wang, Hongyue
    Gelfond, Daniel
    Roach, Christine
    Rowe, Steven M.
    Clancy, John P.
    Sagel, Scott D.
    Borowitz, Drucy
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 75 (01): : 42 - 47
  • [28] COST EFFECTIVENESS OF IVACAFTOR AND LUMACAFTOR COMBINATION FOR THE TREATMENT OF PATIENTS WITH CYSTIC FIBROSIS IN THE UNITED STATES
    Sharma, D.
    Xing, S.
    Hung, Y.
    Caskey, R. N.
    Dowell, M. L.
    Touchette, D. R.
    VALUE IN HEALTH, 2016, 19 (07) : A431 - A432
  • [29] Ivacaftor in adults with cystic fibrosis: one-year experience in the real world setting
    Trinh, I.
    Bermudez, E.
    Abbas, N.
    Viguier, F.
    Hubert, D.
    Guerin, C.
    Chast, F.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1331 - 1331
  • [30] Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-study
    Donaldson, Scott H.
    Laube, Beth L.
    Mogayzel, Peter
    Corcoran, Timothy E.
    Pilewski, Joseph M.
    Ceppe, Agathe
    Wu, Jihong
    Bhambhvani, Pradeep G.
    Ratjen, Felix
    Sagel, Scott D.
    Clancy, J. P.
    Rowe, Steven M.
    Bennett, William D.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (01) : 143 - 145
12345